Grant of Options

RNS Number : 5527N
Judges Scientific PLC
23 January 2023
 

Press Release

 

 

 

Judges Scientific plc

 

("Judges Scientific" or the "Company")

 

Grant of Options

Judges Scientific announces that it has issued options over 13,500 new ordinary shares of 5 pence each in the Company ("Ordinary Shares") at an exercise price of £80.00, being the closing mid price on 20 January 2023.

 

13,500 options have been awarded in total by the Remuneration Committee to the Executive Directors to retain and incentivise them. Vesting of the options after three years is subject to the achievement of 10% compound growth in adjusted earnings per share over the vesting period, and to continued employment.

 

Director

Number of options

Option Scheme

Vesting date

Expiry date

David Cicurel

4,500

Approved/Unapproved

20/01/2026

19/01/2033

Brad Ormsby

4,500

Unapproved

20/01/2026

19/01/2033

Mark Lavelle

4,500

Unapproved

20/01/2026

19/01/2033

 

Ends -  

For further information please contact:

Judges Scientific

 

 

David Cicurel, CEO

Brad Ormsby, Group FD

Tel: +44 (0) 20 3829 6970


 

Shore Capital (Nominated Adviser & Broker)


Stephane Auton

Iain Sexton

Tel: +44 (0) 20 7408 4090

 

Liberum (Joint Broker)

Edward Mansfield

William Hall

 

Media enquiries:

Alma PR (Financial Public Relations)

 

Tel : +44 (0) 20 3100 2222

 

Sam Modlin

Justine James

Joe Pederzolli

 

Tel: +44 (0) 20 3405 0205

judges@almapr.co.uk

 

Notes to editors:  

Judges Scientific plc (AIM: JDG), is a group focused on acquiring and developing companies in the scientific instrument sector.  The Group now consists of 20 businesses acquired since 2005.

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, scientific research facilities, manufacturers and regulatory authorities.  The UK is a recognised centre of excellence for scientific instruments.  The Group has received five Queen's Awards for innovation and export.

The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash.  Shareholder returns are created through the reduction of debt, organic growth and dividends.

For further information, please visit  www.judges.uk.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBGGDBLDDDGXX
UK 100

Latest directors dealings